Advertisement

Search Results for "Apl Autologous Pbsct"

12:03 EDT 25th May 2013 | BioPortfolio

Original Source: Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review.

We retrospectively analyzed the outcomes of 26 patients with acute promyelocytic leukemia (APL) in the first CR (CR1) or second CR (CR2), who underwent autologous PBSCT (auto-PBSCT) between 1992 and 2008. All patients received all-trans retinoic acid-based induction therapy. After two courses of consolidation chemotherapy, upfront auto-PBSCT was performed in 20 patients in the CR1. Five patients had a high WBC count of more than 10 x 10(9)/L (high risk), while 15 patients had a count of less than 10 x 10(9)...

Matching Channels

Matching News

Tandem autologous vs autologous plus reduced intensity allogeneic transplantation in the upfront management of multiple myeloma: meta-analysis of trials with biological assignment

Andrew wins FDA nod for Autologous Fat Transfer device

Andrew Technologies has obtained 510 (k) clearance from the US Food and Drug Administration (FDA) for its Autologous Fat Transfer device.

Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial

Objective To assess the effectiveness of two peritendinous autologous blood injections in addition to a standardised eccentric calf strengthening programme in improving pain and function in patients.....

News and press releases: CellSeed Europe Ltd. withdraws its marketing authorisation application for OraNera (autologous oral mucosal epithelial cells)

The European Medicines Agency has been formally notified by CellSeed Europe Ltd. of its decision to withdraw its application for a centralised marketing authorisation for the medicine OraNera (autolog...

News and press releases: CellSeed Europe Ltd. withdraws its marketing-authorisation application for OraNera (autologous oral mucosal epithelial cells)

The European Medicines Agency has been formally notified by CellSeed Europe Ltd. of its decision to withdraw its application for a centralised marketing authorisation for the medicine OraNera (autolog...

[Articles] Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study

An acellularised deceased donor vein graft recellularised with autologous stem cells can be considered for patients in need of vascular vein shunts without the need for immunosuppression.

Lonza to manufacture autologous virally-transfected T-cell product

Lonza will initiate new autologous virally-transfected T-cell product manufacturing in new cGMP viral immunotherapy manufacturing suites in Houston, Texas, US.

Return to recreational sports likely after autologous knee cartilage transplant

NEW YORK (Reuters Health) - Five years after knee cartilage repair using matrix-associated autologous chondrocytes, most patients have returned to their preinjury level of recreational sports, res...

Matching PubMed Articles

Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory or Relapsed Lymphoma: Results of Children's Oncology Group Study A5962.

PURPOSE: This prospective study was designed to determine the safety and efficacy of cyclophosphamide, BCNU and etoposide (CBV) conditioning and autologous peripheral blood stem cell transplant (PBSCT...

Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review.

We retrospectively analyzed the outcomes of 26 patients with acute promyelocytic leukemia (APL) in the first CR (CR1) or second CR (CR2), who underwent autologous PBSCT (auto-PBSCT) between 1992 and 2...

Comparable Analysis of Outcomes for Allogeneic Peripheral Blood Stem Cell Transplantation from Matched Related and Matched Unrelated Donors in Acute Myeloid Leukemia.

This study compared the results of allogeneic peripheral blood stem cell transplantation (PBSCT) from unrelated and related donors in 142 consecutive patients with acute myeloid leukemia (AML). The cu...

Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.

The efficacy of high-dose chemotherapy followed by autologous hematopoietic SCT for relapsed diffuse large B-cell lymphoma (DLBCL) has been reported, but an optimal conditioning regimen has not been d...

A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response.

Background A majority of multiple myeloma (MM) patients fail to achieve complete response (CR) to peripheral blood stem cell transplantation (PBSCT); effective options following autologous transplanta...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement